Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,265
datasets available to search
ShareScore release 0.9.0
Dataset results
1,265 results for “ATOPIC DERMATITIS”
A Study to Determine the Safety and Tolerability of Dupilumab (REGN668/SAR231893) in Patients Aged ≥6 to <18 Years With Atopic Dermatitis (Eczema)
ClinicalTrials.gov study NCT02407756. IPD Sharing: Not stated. Countries: 6. Publications: 2.
Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)
ClinicalTrials.gov study NCT03569293. IPD Sharing: YES. Countries: 25. Publications: 13.
Crisaborole Ointment 2% Skin Biomarker Biopsy Study in Atopic Dermatitis
ClinicalTrials.gov study NCT03233529. IPD Sharing: YES. Countries: 1. Publications: 1.
Evaluation of the Efficacy of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients
ClinicalTrials.gov study NCT03158012. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis
ClinicalTrials.gov study NCT03745638. IPD Sharing: NO. Countries: 7. Publications: 7.
Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic Dermatitis
ClinicalTrials.gov study NCT04598269. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety Study of Orally Administered DS107 in Moderate to Severe Atopic Dermatitis Patients
ClinicalTrials.gov study NCT02864498. IPD Sharing: Not stated. Countries: 2. Publications: 21.
A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT03733301. IPD Sharing: YES. Countries: 10. Publications: 6.
Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
ClinicalTrials.gov study NCT02277743. IPD Sharing: Not stated. Countries: 10. Publications: 18.
Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)
ClinicalTrials.gov study NCT03992417. IPD Sharing: YES. Countries: 22. Publications: 2.
Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (Integument-PED)
ClinicalTrials.gov study NCT04845620. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis
ClinicalTrials.gov study NCT03334435. IPD Sharing: YES. Countries: 19. Publications: 6.
A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT03334396. IPD Sharing: YES. Countries: 10. Publications: 5.
Immune Response to Yellow Fever Vaccination in Adults With Atopic Dermatitis
ClinicalTrials.gov study NCT00723489. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis
ClinicalTrials.gov study NCT02347176. IPD Sharing: Not stated. Countries: 6. Publications: 2.
TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis
ClinicalTrials.gov study NCT03745651. IPD Sharing: NO. Countries: 7. Publications: 9.
A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT04800315. IPD Sharing: YES. Countries: 6. Publications: 1.
A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab
ClinicalTrials.gov study NCT05369403. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis
ClinicalTrials.gov study NCT04040192. IPD Sharing: YES. Countries: 6. Publications: 2.
Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)
ClinicalTrials.gov study NCT03160885. IPD Sharing: NO. Countries: 9. Publications: 7.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.